The U-M-led development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials.
This phase 2 trial also identified a subset of patients with specific mutations who may see the most benefit from the drug.
How E coli. and other illness-causing bugs get past the microbiome’s defenses.
Women with Inflammatory Breast Cancer Are Living Longer, But the Gap Between White and Black Patients Persists
A U-M Rogel Cancer study provides an updated, more comprehensive look at trends for this rare, aggressive form of breast cancer over the last four decades.
Michigan Medicine ophthalmologists create a scalable algorithm for triaging appointments during the pandemic